CHIP Updates Series
Notes from the Editors: Highlights from CTO Connect 2021
BY ROBERT F. RILEY | MARCH 11, 2021
Welcome to the latest TCTMD CHIP updates. This month we feature several lectures from CTO Connect 2021. With over 7,000 registered attendees, this meeting is truly a premier online chronic total occlusion (CTO) education experience. To begin, Robert Riley, MD (The Christ Hospital, Cincinnati, OH), and James Spratt, MD (St George’s, London, England), co-moderate a session on anterograde wire escalation (AWE) that features lectures by Hiroyuki Tanaka, MD (Kurashiki Central Hospital, Japan), on the Japanese Expert Registry; by Masahisa Yamane, MD (Saitama-Sekishinkai Hospital, Sayama City, Japan), on new wires for AWE; by Gerald Werner, MD (Darmstadt Clinic, Frankfurt, Germany), on the role of the parallel wire technique; and Satoru Sumitsuji, MD (Osaka University, Suita, Japan), on using IVUS to guide AWE. This was a fantastic session filled with novel procedural pearls to optimized AWE cases.
Coming at CTO recanalization from another angle, Yamane and Masahiko Ochiai, MD, PhD (Showa University Northern Yokohama Hospital, Japan), co-moderate a session on retrograde CTO PCI, featuring lectures by Kambis Mashayekhi, MD (University Heart Center Freiburg, Bad Krozingen, Germany), on using septal and epicardial collaterals, William Nicholson, MD (Emory University, Atlanta, GA), on using saphenous vein grafts as conduits for retrograde CTO PCI, Paul Hsien-Li Kao, MD (National Taiwan University Hospital, Taipei), on contemporary versus traditional rCART, and Rhian Davies, DO (WellSpan Health, York, PA), on the role of CART in contemporary CTO PCI. We also want to highlight the multitude of live cases presented during the conference that illustrate everything from technique to complication management. The cases truly crystalize many of the didactics in a way slides often don’t convey!
Thank you for your continued support as we strive to offer you the best and most up-to-date content for our CHIP community.
Latest CHIP News
With varying sensitivity and precision for identifying STEMI, a healthy skepticism of STEMI care data is warranted, say docs.
“To be able to help a patient, that device is only really a small part in the total care you give,” the review’s lead author says.
Two new papers highlight the need for optimal revascularization, but debate will go on over angina relief versus harder outcomes.